1 completed, 1 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow CDP323: new trials by email Literature Review of CDP323 trials Research Report on CDP323
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CDP323 Biomarker Study CDP323, Placebo - Relapsing Multiple Sclerosis | Phase 1 / Phase 2 | Completed | UCB Pharma | 71 | 2008-07-01 | 2011-09-12 |
| Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323 CDP323, placebo - Multiple Sclerosis | Phase 2 | Terminated | UCB Pharma | 232 | 2007-05-01 | 2011-09-12 |
UCB Pharma (2)
United Kingdom (2) · Belgium (1) · Canada (1) · Finland (1) · France (1) · Germany (1) · Hungary (1) · Netherlands (1) · Spain (1) · Sweden (1) · United States (1)